[1]
|
Watkins P A,Maiguel D,Jia Z,Pevsner J. Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome[J]. J Lipid Res,2007,48(12):2736-2750. doi: 10.1194/jlr.M700378-JLR200
|
[2]
|
Watkins P A. Fatty acid activation[J]. Prog Lipid Res,1997,36(1):55-83. doi: 10.1016/S0163-7827(97)00004-0
|
[3]
|
Christensen E,Hagve T A,Grønn M,et al. Beta-oxidation of medium chain (C8-C14) fatty acids studied in isolated liver cells[J]. Biochim Biophys Acta,1989,1004(2):187-195. doi: 10.1016/0005-2760(89)90267-1
|
[4]
|
Bach A C,Ingenbleek Y,Frey A. The usefulness of dietary medium-chain triglycerides in body weight control: fact or fancy?[J]. J Lipid Res,1996,37(4):708-726. doi: 10.1016/S0022-2275(20)37570-2
|
[5]
|
黄威,程忠平. 脂肪酸代谢与肿瘤的发生、发展和转移的关系[J]. 肿瘤研究与临床,2018,30(12):879-882. doi: 10.3760/cma.j.issn.1006-9801.2018.12.016
|
[6]
|
Warburg O. On the origin of cancer cells[J]. Science,1956,123(3191):309-314. doi: 10.1126/science.123.3191.309
|
[7]
|
Zaidi N,Lupien L,Kuemmerle N B,et al. Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids[J]. Prog Lipid Re,2013,52(4):585-589. doi: 10.1016/j.plipres.2013.08.005
|
[8]
|
Menendez J A,Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis[J]. Nat Rev Cancer,2007,7(10):763-777. doi: 10.1038/nrc2222
|
[9]
|
Fujino T,Takei Y A,Sone H,et al. Molecular identification and characterization of two medium-chain acyl-CoA synthetases,MACS1 and the Sa gene product[J]. J Biol Chem,2001,276(38):35961-35966. doi: 10.1074/jbc.M106651200
|
[10]
|
Vessey D A,Kelley M,Warren R S. Characterization of the CoA ligases of human liver mitochondria catalyzing the activation of short- and medium-chain fatty acids and xenobiotic carboxylic acids[J]. Biochim Biophys Acta,1999,1428(2-3):455-462. doi: 10.1016/S0304-4165(99)00088-4
|
[11]
|
Celis J E,Gromov P,Cabezón T,et al. 15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma[J]. Mol Cell Proteomics,2008,7(10):1795-1809. doi: 10.1074/mcp.R800011-MCP200
|
[12]
|
Celis J E,Cabezón T,Moreira J M,et al. Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort[J]. Mol Oncol,2009,3(3):220-237. doi: 10.1016/j.molonc.2009.01.005
|
[13]
|
Bockmayr M, Klauschen F, Györffy B, et al New network topology approaches reveal differential correlation patterns in breast cancer[J]. BMC Syst Biol, 2013, 7: 78.
|
[14]
|
Guo Y,Ren C,Huang W,et al. Oncogenic ACSM1 in prostate cancer is through metabolic and extracellular matrix-receptor interaction signaling pathways[J]. Am J Cancer Res,2022,12(4):1824-1842.
|
[15]
|
van der Sluis R. Analyses of the genetic diversity and protein expression variation of the acyl: CoA medium-chain ligases,ACSM2A and ACSM2B[J]. Mol Genet Genomics,2018,293(5):1279-1292. doi: 10.1007/s00438-018-1460-3
|
[16]
|
Agúndez J A,Martínez C,Pérez-Sala D,et al. Pharmacogenomics in aspirin intolerance[J]. Curr Drug Metab,2009,10(9):998-1008. doi: 10.2174/138920009790711814
|
[17]
|
Watanabe H,Paxton R L,Tolerico M R,et al. Expression of Acsm2,a kidney-specific gene,parallels the function and maturation of proximal tubular cells[J]. Am J Physiol Renal Physiol,2020,319(4):F603-F611. doi: 10.1152/ajprenal.00348.2020
|
[18]
|
Iwai N,Mannami T,Tomoike H,et al. An acyl-CoA synthetase gene family in chromosome 16p12 may contribute to multiple risk factors[J]. Hypertension,2003,41(5):1041-1046. doi: 10.1161/01.HYP.0000064944.60569.87
|
[19]
|
Samani N J,Whitmore S A,Kaiser M A,et al. Chromosomal assignment of the human SA gene to 16p13.11 and demonstration of its expression in the kidney[J]. Biochem Biophys Res Commun,1994,199(2):862-868. doi: 10.1006/bbrc.1994.1308
|
[20]
|
Iwai N,Katsuya T,Mannami T,et al. Association between SAH,an acyl-CoA synthetase gene,and hypertriglyceridemia,obesity,and hypertension[J]. Circulation,2002,105(1):41-47. doi: 10.1161/hc0102.101780
|
[21]
|
Telgmann R,Brand E,Nicaud V,Hagedorn C,et al. SAH gene variants are associated with obesity-related hypertension in Caucasians: the PEGASE Study[J]. J Hypertens,2007,25(3):557-564. doi: 10.1097/HJH.0b013e3280144779
|
[22]
|
Lin M W,Hwu C M,Liou T L,et al. Human SA gene polymorphisms are associated with non-high-density lipoprotein cholesterol in postmenopausal women: A pilot study[J]. Maturitas,2009,62(1):66-71. doi: 10.1016/j.maturitas.2008.11.002
|
[23]
|
Ruan H Y,Yang C,Tao X M,et al. Downregulation of ACSM3 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma[J]. Am J Cancer Res,2017,7(3):543-553.
|
[24]
|
Zhu Z,Wang D,Shen Y. Loss of ACSM3 confers worsened prognosis and immune exclusion to cutaneous melanoma[J]. J Cancer,2020,11(22):6582-6590. doi: 10.7150/jca.48354
|
[25]
|
Yan L,He Z,Li W,et al. The Overexpression of acyl-CoA medium-Chain synthetase-3 (ACSM3) suppresses the ovarian cancer progression via the inhibition of integrin β1/AKT signaling pathway[J]. Front Oncol,2021,11:644840.
|
[26]
|
Yang X,Wu G,Zhang Q,et al. ACSM3 suppresses the pathogenesis of high-grade serous ovarian carcinoma via promoting AMPK activity[J]. Cell Oncol (Dordr),2022,45(1):151-161.
|
[27]
|
Yates A,Akanni W,Amode M R,et al. Ensembl 2016[J]. Nucleic Acids Res,2016,44(D1):D710-716. doi: 10.1093/nar/gkv1157
|
[28]
|
Guzmán-FµLgencio M,Jiménez J L,Jiménez-Sousa M A,et al. ACSM4 polymorphisms are associated with rapid AIDS progression in HIV-infected patients[J]. J Acquir Immune Defic Syndr,2014,65(1):27-32. doi: 10.1097/QAI.0b013e3182a990e2
|
[29]
|
Hendrickson S L,Lautenberger J A,Chinn L W,et al. Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression[J]. PLoS One,2010,5(9):e12862.
|
[30]
|
van der Sluis R,Erasmus E. Xenobiotic/medium chain fatty acid: CoA ligase - a critical review on its role in fatty acid metabolism and the detoxification of benzoic acid and aspirin[J]. Expert Opin Drug Metab Toxicol,2016,12(10):1169-1179. doi: 10.1080/17425255.2016.1206888
|
[31]
|
Alsaleem M A,Ball G,Toss M S,et al. A novel prognostic two-gene signature for triple negative breast cancer[J]. Mod Pathol,2020,33(11):2208-2220. doi: 10.1038/s41379-020-0563-7
|
[32]
|
Stelzer G,Rosen N,Plaschkes I,et al. The GeneCards Suite:From Gene Data Mining to Disease Genome Sequence Analyses[J]. Curr Protoc Bioinformatics,2016,54:1.30.1-1.30.33.
|
[33]
|
Hisanaga Y,Ago H,Nakagawa N,et al. Structural basis of the substrate-specific two-step catalysis of long chain fatty acyl-CoA synthetase dimer[J]. J Biol Chem,2004,279(30):31717-31726. doi: 10.1074/jbc.M400100200
|
[34]
|
Weimar J D,DiRusso C C,Delio R,et al. Functional role of fatty acyl-coenzyme A synthetase in the transmembrane movement and activation of exogenous long-chain fatty acids. Amino acid residues within the ATP/AMP signature motif of Escherichia coli FadD are required for enzyme activity and fatty acid transport[J]. J Biol Chem,2002,277(33):29369-29376. doi: 10.1074/jbc.M107022200
|
[35]
|
Zou Z,DiRusso C C,Ctrnacta V,et al. Fatty acid transport in Saccharomyces cerevisiae. Directed mutagenesis of FAT1 distinguishes the biochemical activities associated with Fat1p[J]. J Biol Chem,2002,277(34):31062-31071. doi: 10.1074/jbc.M205034200
|
[36]
|
Du J,Wang X,Nie Q,et al. Computational study of the binding mechanism of medium chain acyl-CoA synthetase with substrate in Methanosarcina acetivorans[J]. J Biotechnol,2017,259:160-167.
|
[37]
|
Revilla M,Puig-Oliveras A,Crespo-Piazuelo D,et al. Expression analysis of candidate genes for fatty acid composition in adipose tissue and identification of regulatory regions[J]. Sci Rep,2018,8(1):2045. doi: 10.1038/s41598-018-20473-3
|
[38]
|
Criado-Mesas L,Ballester M,Crespo-Piazuelo D. Identification of eQTLs associated with lipid metabolism in Longissimus dorsi muscle of pigs with different genetic backgrounds[J]. Sci Rep,2020,10(1):9845. doi: 10.1038/s41598-020-67015-4
|
[39]
|
Puig-Oliveras A,Revilla M,Castelló A,et al. Author Correction:Expression-based GWAS identifies variants,gene interactions and key regulators affecting intramuscular fatty acid content and composition in porcine meat[J]. Sci Rep,2022,12(1):4902.
|
[40]
|
Koseler A,Ma F,Kilic I D,et al. Genome-wide DNA methylation profiling of blood from monozygotic twins discordant for myocardial infarction[J]. In Vivo,2020,34(1):361-367. doi: 10.21873/invivo.11782
|
[41]
|
Luo Z H,Liu Z W,Mao Y,et al. Cajanolactone A,a stilbenoid from cajanus cajan,prevents ovariectomy-induced obesity and liver steatosis in mice fed a regular diet[J]. Phytomedicine,2020,78:153290.
|
[42]
|
Ma C,Luo H,Cao J,et al. Identification of a Novel tumor microenvironment-associated eight-gene signature for prognosis prediction in lung adenocarcinoma[J]. Front Mol Biosci,2020,7:571641.
|
[43]
|
Grupe A,Li Y,Rowland C,et al. A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease[J]. Am J Hum Genet,2006,78(1):78-88. doi: 10.1086/498851
|
[44]
|
Zhao Z,Zhan Y,Jing L,et al. KLF10 upregulates ACSM3 via the PI3K/Akt signaling pathway to inhibit the malignant progression of melanoma[J]. Oncol Lett,2022,23(6):175.
|
[45]
|
Xu R,Qi L,Ren X,et al. Integrated Analysis of TME and hypoxia identifies a classifier to predict prognosis and therapeutic biomarkers in soft tissue sarcomas[J]. Cancers (Basel),2022,14(22):5675.
|
[46]
|
Guo X,Xiong H,Dong S,et al. Identification and validation of a novel immune infiltration-based diagnostic score for early detection of hepatocellular carcinoma by machine-learning strategies[J]. Gastroenterol Res Pract,2022,2022:5403423.
|
[47]
|
Ruan X,Tian M,Kang N,et al. Genome-wide identification of m6A-associated functional SNPs as potential functional variants for thyroid cancer[J]. Am J Cancer Res,2021,11(11):5402-5414.
|